Feasibility of a therapeutic exercise before total hip replacement

ISRCTN ISRCTN09005050
DOI https://doi.org/10.1186/ISRCTN09005050
Secondary identifying numbers N/A
Submission date
02/09/2009
Registration date
26/10/2009
Last edited
26/10/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Nico van Meeteren
Scientific

Hospital Gelderse Vallei
Willy Brandtlaan 10
Ede
6716 RP
Netherlands

Email VeldmanA@zgv.nl

Study information

Study designRandomised controlled single-blind pilot trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific titleFeasibility and preliminary effectiveness of a short-term, preoperative therapeutic exercise programme for frail, elderly patients awaiting total hip replacement
Study acronymProfyt2
Study objectivesIs a short-term preoperative therapeutic intervention for frail elderly patients with osteoarthritis awaiting total hip replacement feasible?
Ethics approval(s)Institutional Review Board of the University Medical Centre Utrecht (protocol number 07/051) and the Gelderse Vallei Hospital (protocol number Profyt 06/184-O) approved this study on the 5th June 2007.
Health condition(s) or problem(s) studiedHip osteoarthritis
InterventionExperimental group: Short-term (3-6 weeks), intensive, tailor-made therapeutic exercise (twice a week).
Usual care group: One information meeting and practicing the use of crutches.
Intervention typeOther
Primary outcome measureFeasibility towards patients satisfactory is assessed by the following main outcomes:
1. The occurrence of adverse effects during testing or training. Participants will have to register any discomforted, stiffness or other adverse events in their diary.
2. Adherence to the treatment. Both groups are asked to register their adherence to the home based training programme (i.e. time exercised, days exercised and perceived exertion). Pedometer adherence is defined as the number of steps recorded on the daily pedometer log that met or surpassed the weekly goal. Also adequate use of the diary will be assessed as part of the adherence to the intervention.
3. The patients' appreciation and motivation towards the therapeutic intervention will be determined by a patient evaluation form (satisfaction questionnaire) that patients complete at the end of the preoperative training.
Secondary outcome measures1. Preoperative effectiveness:
1.1. Aerobic capacity, assessed with the Physical Working Capacity 170
1.2. Strength and power of the lower limb muscles is assessed by the chair rise time
1.3. Functional mobility is assessed with the Timed Up and Go Test
1.4. Walking capacity is assessed with the six minutes walk test (6MWT)
1.5. Pain, functioning and quality of life is assessed with the Hip disability and Osteoarthritis Outcome Score (HOOS)
1.6. Patient specific complaint (Patient Specifieke Klacht [PSK]) questionnaire
1.7. Functional activities are assessed by the Longitudinal Aging Study Amsterdam (LASA) Physical Activity Questionnaire (LAPAQ)

2. Postoperative effectiveness:
2.1. Length of stay
2.2. Discharge destination (home, rehabilitation centre or nursing home)
2.3. The patient's functional mobility score using the Iowa Level of Assistance Scale
Overall study start date05/06/2007
Completion date09/11/2008

Eligibility

Participant type(s)Patient
Age groupSenior
SexBoth
Target number of participants20
Key inclusion criteria1. Both males and females, age ≥70 years
2. Scheduled for elective total hip arthroplasty (THA) (minimum waiting period of 3 weeks)
3. Osteoarthritis is the motive for the THA
4. First surgical intervention of this pathology
5. Scores ≥2 on the Clinical Frailty Scale (CFS)
6. Able to permit time for the intervention between enrolment and surgery
Key exclusion criteria1. Unable to understand Dutch
2. Patients with severe heart disease
Date of first enrolment05/06/2007
Date of final enrolment09/11/2008

Locations

Countries of recruitment

  • Netherlands

Study participating centre

Hospital Gelderse Vallei
Ede
6716 RP
Netherlands

Sponsor information

Hospital Gelderse Vallei (Netherlands)
Hospital/treatment centre

Willy Brandtlaan 10
Ede
6716 RP
Netherlands

Website http://www.zgv.nl
ROR logo "ROR" https://ror.org/03862t386

Funders

Funder type

Hospital/treatment centre

Hospital Gelderse Vallei (Netherlands)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan